Base excision repair regulates PD-L1 expression in cancer cells
Programmed death-ligand 1 (PD-L1) is a key factor influencing cancer immunotherapy; however, the regulation of PD-L1 expression in cancer cells remains unclear, particularly regarding DNA damage, repair and its signalling. Herein, we demonstrate that oxidative DNA damage induced by exogenously appli...
Gespeichert in:
Veröffentlicht in: | Oncogene 2019-06, Vol.38 (23), p.4452-4466 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Programmed death-ligand 1 (PD-L1) is a key factor influencing cancer immunotherapy; however, the regulation of PD-L1 expression in cancer cells remains unclear, particularly regarding DNA damage, repair and its signalling. Herein, we demonstrate that oxidative DNA damage induced by exogenously applied hydrogen peroxide (H
2
O
2
) upregulates PD-L1 expression in cancer cells. Further, depletion of the base excision repair (BER) enzyme DNA glycosylase augments PD-L1 upregulation in response to H
2
O
2
. PD-L1 upregulation in BER-depleted cells requires ATR/Chk1 kinase activities, demonstrating that PD-L1 upregulation is mediated by DNA damage signalling. Further analysis of The Cancer Genome Atlas revealed that the expression of PD-L1 is negatively correlated with that of the BER/single-strand break repair (SSBR) and tumours with low BER/SSBR gene expression show high microsatellite instability and neoantigen production. Hence, these results suggest that PD-L1 expression is regulated in cancer cells via the DNA damage signalling and neoantigen–interferon-γ pathway under oxidative stress.
Highlights
Exogenous oxidative DNA damage upregulates PD-L1 expression in cancer cells.
BER deficiency augments PD-L1 upregulation following oxidative DNA damage.
Tumour samples with BER/SSBR mutations show high microsatellite instability, neoantigen and PD-L1 expression.
PD-L1 and BER/SSBR gene expressions are negatively correlated in clinical specimens. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/s41388-019-0733-6 |